Who owns ACASTI PHARMA INC?
- Ticker: GRCE
- CUSIP Number: 00439u104
Tip: Access positions for across all investors
Analyze quarterly positions in Acasti Pharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csvTop investors of Acasti Pharma stock
Who bought or sold ACASTI PHARMA INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Nantahala Capital Management | 1.2M | $3.5M | 0% | Sep 2025 |
|
| AIGH Capital Management | 907k | $2.7M | -20% | Sep 2025 |
|
| Vanguard Group | 409k | $1.2M | 0% | Sep 2025 |
|
| ADAR1 Capital Management | 351k | $1.0M | 98% | Sep 2025 |
|
| Stonepine Capital Management | 211k | $628k | -28% | Sep 2025 |
|
| Renaissance Technologies | 85k | $252k | 206% | Sep 2025 |
|
| Citadel Advisors | 27k | $81k | -21% | Sep 2025 |
|
| Millington Financial Advisors | 20k | $60k | 0% | Sep 2025 |
|
| SeaCrest Wealth Management | 14k | $42k | 100% | Sep 2025 |
|
| National Bank Of Canada /fi/ | 2.7k | $8.0k | 0% | Sep 2025 |
|
| Morgan Stanley | 1.8k | $5.5k | 100% | Jun 2025 |
|
| Tower Research Capital | 1.6k | $4.8k | 19% | Sep 2025 |
|
| Royal Bank of Canada | 571.00 | $2.1k | 5% | Sep 2025 |
|
| Activest Wealth Management | 104.00 | $310.003200 | 0% | Sep 2025 |
|
| SBI Securities | 101.00 | $301.000200 | 0% | Sep 2025 |
|
| Steward Partners Investment Advisory | 41.00 | $121.999600 | 0% | Sep 2025 |
|
| Nbc Securities | 2.00 | $5.000000 | 100% | Sep 2025 |
|
| Federation des caisses Desjardins du Quebec | 1.00 | $3.000000 | 0% | Sep 2025 |
|
Who sold out of Acasti Pharma?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Palumbo Wealth Management | Jun 2025 | 49k | $144k |
| Jones Financial Companies, L.L | Jun 2025 | 29.00 | $85.999500 |
| Jpmorgan Chase & Co | Mar 2025 | 15.00 | $34.000500 |